Sign inGet started

Collins Cooper C.

Insider CIK 1485508 · PTX Chief Strategic Officer, Director, 10% owner · TXMD Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TXMD TherapeuticsMD, Inc. A Award deriv2025-11-032025-11-058,500— $08,500SEC↗
TXMD TherapeuticsMD, Inc. M Exercise deriv2025-02-182025-02-208,500— $00SEC↗
TXMD TherapeuticsMD, Inc. M Exercise2025-02-182025-02-208,500— $060,516SEC↗
TXMD TherapeuticsMD, Inc. P Buy2024-08-222024-08-264,094$1.73 $7.1K52,016SEC↗
TXMD TherapeuticsMD, Inc. P Buy2024-08-212024-08-231,200$1.70 $2.0K47,922SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2023-07-172023-07-198,500— $08,500SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2022-09-292022-10-035,000— $05,000SEC↗
TXMD TherapeuticsMD, Inc. M Exercise deriv2022-08-182022-08-221,984— $00SEC↗
TXMD TherapeuticsMD, Inc. M Exercise2022-08-182022-08-221,984— $046,722SEC↗
TXMD TherapeuticsMD, Inc. P Buy2021-11-182021-11-221,000,000$0.58 $580.0K2,236,864SEC↗
TXMD TherapeuticsMD, Inc. P Buy2021-08-182021-08-19900,000$0.72 $648.0K1,236,864SEC↗
TXMD TherapeuticsMD, Inc. P Buy2021-08-172021-08-19100,000$0.77 $77.0K336,864SEC↗
TXMD TherapeuticsMD, Inc. M Exercise deriv2021-08-102021-08-1296,864— $00SEC↗
TXMD TherapeuticsMD, Inc. M Exercise2021-08-102021-08-1296,864— $0236,864SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2021-07-012021-07-0299,174— $099,174SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2020-06-182020-06-1996,864— $096,864SEC↗
TXMD TherapeuticsMD, Inc. P Buy2020-06-092020-06-1047,500$1.45 $68.9K140,000SEC↗
TXMD TherapeuticsMD, Inc. P Buy2020-06-082020-06-1026,500$1.45 $38.4K92,500SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2019-06-202019-06-2475,000— $075,000SEC↗
TXMD TherapeuticsMD, Inc. P Buy2019-05-132019-05-1530,000$3.33 $99.9K66,000SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2018-07-022018-07-0550,000— $050,000SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2017-06-212017-06-2350,000— $050,000SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2016-12-212016-12-2225,000— $025,000SEC↗
TXMD TherapeuticsMD, Inc. P Buy2016-03-112016-03-1416,000$6.23 $99.7K36,000SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2015-12-172015-12-2150,000— $050,000SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2015-03-252015-03-26100,000— $0100,000SEC↗
TXMD TherapeuticsMD, Inc. P Buy2014-06-052014-06-0920,000$3.84 $76.8K20,000SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-04-022014-04-0223,898$5.19 $124.0K2,500,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-04-012014-04-0266,102$5.28 $349.0K2,523,944SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-03-042014-03-053,500,000$3.40 $11.90M2,590,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-03-042014-03-0547,195$3.59 $169.4K6,090,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-03-032014-03-0542,805$3.61 $154.5K6,137,241SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-02-052014-02-051,730$3.53 $6.1K6,193,116SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-02-052014-02-0513,070$2.56 $33.5K6,180,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-02-042014-02-0542,500$2.11 $89.7K6,194,846SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-02-032014-02-0532,700$2.16 $70.6K6,237,346SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-01-072014-01-0827,962$2.20 $61.5K6,270,046SEC↗
TXMD TherapeuticsMD, Inc. X Exercise deriv2014-01-062014-01-0870,000— $0220,000SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-01-062014-01-0628,443$2.23 $63.4K6,298,008SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-01-032014-01-066,195$2.42 $15.0K6,326,451SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2014-01-022014-01-0627,400$2.46 $67.4K6,332,646SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-12-062013-12-1017,500$2.29 $40.1K6,360,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-12-052013-12-1019,952$2.33 $46.5K6,377,546SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-12-042013-12-0431,019$2.38 $73.8K6,397,498SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-12-032013-12-047,429$2.48 $18.4K6,428,517SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-12-022013-12-0414,100$2.55 $36.0K6,435,946SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-11-052013-11-0530,239$1.99 $60.2K6,450,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-11-042013-11-0515,200$2.01 $30.6K6,480,285SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-11-012013-11-0544,561$2.01 $89.6K6,495,485SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-10-082013-10-08200$2.51 $5026,540,046SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-10-072013-10-0812,379$2.49 $30.8K6,540,246SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-10-042013-10-0810,785$2.45 $26.4K6,552,625SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-10-032013-10-0325,700$2.46 $63.2K6,563,410SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-10-022013-10-0313,200$2.57 $33.9K6,589,110SEC↗
PTX PERNIX THERAPEUTICS HOLDIN S Sale2013-10-012013-10-0327,736$2.61 $72.4K6,602,310SEC↗
PTX PERNIX THERAPEUTICS HOLDIN J Other2013-07-242013-07-251,250,000$4.04 $5.05M6,630,046SEC↗
TXMD TherapeuticsMD, Inc. S Sale2013-06-142013-06-172,631,579$1.75 $4.61M0SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2013-05-012013-05-0375,000— $0150,000SEC↗
TXMD TherapeuticsMD, Inc. A Award deriv2012-04-162012-04-1775,000— $075,000SEC↗